Overview

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability and efficacy of SU011248 in patients with non-small cell lung cancer with brain metastases.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Sunitinib